Delivery Order SPE2DB20D1100-SPE2DB24FA5J5
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,906.35, is for the supply of 1 mg vials of the pharmaceutical drug remifentanil. The delivery order has an ultimate completion date of March 11, 2024. Additionally, AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 1 mg vials of the drug remifentanil. The $6,251.35 contract has an ultimate completion date of March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. The delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REMIFENTANIL 1 MG VIALS. The order, valued at $1,063.41, has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing pharmaceutical products and medical supplies to...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award is for the delivery of Remifentanil 1 mg vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,068.69 and a completion date of January 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,081.55 to supply Remifentanil 2 mg vials, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $1,326.80 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with a completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a short-acting synthetic opioid commonly used in surgical and acute care medical settings, making...
- The Defense Logistics Agency awarded a $9,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 2 mg vials of the opioid analgesic remifentanil. Performance will take place in Conshohocken, Pennsylvania over a one-day period concluding on August 30, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling the Defense Logistics Agency's requirement for this controlled pharmaceutical under an unstated...
- The Defense Logistics Agency awarded a $2,194.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562117118 REMIFENTANIL 1 MG VIALS. The place of performance is Conshohocken, Pennsylvania. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which provides pharmaceuticals and other medical supplies to support Department of Defense programs. No subcontractors or set aside designations were indicated. Amerisourcebergen Corporation will fulfill...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 2 MG VIALS. The contract has a ceiling value of $3,837.86 and is a Firm Fixed Price Delivery Order with a performance period ending on September 30, 2024. The contract is not subject to any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA5J5Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,461.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 1 mg vials of the pharmaceutical remifentanil. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds with DLA to provide pharmaceutical products and medical supplies in support of military treatment programs and facilities. This IDC was awarded solely to Amerisourcebergen Drug Corp as a single award contract and does not fall under any overarching contract vehicles. No set-aside designations were used for this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 3/4/24 |